Mild cognitive impairment exists in Parkinson's disease

Journal of Neural Transmission

Volumn 118, Issue 8, 2011, Pages 1179-1183

  Rektorova, Irena ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Brain imaging; Executive; Memory; Mild cognitive impairment; Parkinson's disease

Indexed keywords

AMYLOID BETA PROTEIN; ANTIPARKINSON AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; BRAIN METABOLISM; COGNITION; DEMENTIA; DISEASE COURSE; HUMAN; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

HUMANS; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 80051586826     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0674-x     Document Type: Article

References (40)

1. D Aarsland K Andersen JP Larsen A Lolk P Kragh-Sørensen 2003 Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study Arch Neurol 60 387 392 12633150 10.1001/archneur.60.3.387 (Pubitemid 36314364)
2. D Aarsland K Brønnick JP Larsen OB Tysnes G Alves Norwegian ParkWest Study Group 2009 Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study Neurology 72 1121 1126 19020293 10.1212/01.wnl.0000338632.00552.cb 1:STN:280:DC%2BD1M3ks1Sktg%3D%3D
3. D Aarsland K Bronnick C Williams-Gray, et al. 2010 Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis Neurology 75 1062 1069 20855849 10.1212/WNL.0b013e3181f39d0e 1:STN:280:DC%2BC3cfjslCktw%3D%3D
4. Alves G, Brønnick K, Aarsland D, et al. (2010) CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 81:1080-1086
5. LG Apostolova M Beyer AE Green, et al. 2010 Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia Mov Disord 25 687 688 20437538
6. MK Beyer CC Janvin JP Larsen D Aarsland 2007 A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry J Neurol Neurosurg Psychiatry 78 254 259 17028119 10.1136/jnnp.2006.093849 (Pubitemid 46579662)
7. H Braak K Del Tredici U Rüb RAI de Vos ENH Jansen Steur E Braak 2003 Staging of brain patology related to sporadic Parkinson's disease Neurobiol Aging 24 197 210 12498954 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
8. H Braak U Rub K Del Tredici 2006 Cognitive decline correlates with neuropathological stage in Parkinson's disease J Neurol Sci 248 255 258 16814807 10.1016/j.jns.2006.05.011 (Pubitemid 44647283)
9. JN Caviness E Driver-Dunckley DJ Connor, et al. 2007 Defining mild cognitive impairment in Parkinson's disease Mov Disord 22 1272 1277 17415797 10.1002/mds.21453 (Pubitemid 47325034)
10. R Cools 2006 Dopaminergic modulation of cognitive function implications for l-DOPA treatment in Parkinson's disease Neurosci Biobehav Rev 30 1 23 15935475 10.1016/j.neubiorev.2005.03.024 1:CAS:528:DC%2BD2MXhtlWqtb7F (Pubitemid 41779404)
11. B Dubois 2007 Is PD-MCI a useful concept? Mov Disord 22 1215 1216 17557344 10.1002/mds.21566 (Pubitemid 47325026)
12. B Dubois D Burn C Goetz, et al. 2007 Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force Mov Disord 22 2314 2324 18098298 10.1002/mds.21844 (Pubitemid 351155975)
13. B Dubois HH Feldman C Jacova, et al. 2007 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 734 746 17616482 10.1016/S1474-4422(07)70178-3 (Pubitemid 47058377)
14. M Emre D Aarsland R Brown, et al. 2007 Clinical diagnostic criteria for dementi associated with Parkinson's disease Mov Disord 22 1689 1707 17542011 10.1002/mds.21507 (Pubitemid 47597592)
15. T Foltynie CE Brayne TW Robbins RA Barker 2004 The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain 127 550 560 14691062 10.1093/brain/awh067 (Pubitemid 38295472)
16. R Hilker AV Thomas JC Klein, et al. 2005 Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways Neurology 65 1716 1722 16344512 10.1212/01.wnl.0000191154.78131.f6 1:STN:280: DC%2BD2Mnmt1Ggtw%3D%3D
17. Y Hosokai Y Nishio K Hirayama, et al. 2009 Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment Mov Disord 24 854 862 19199357 10.1002/mds.22444
18. C Huang P Mattis C Tang K Perrine M Carbon D Eidelberg 2007 Metabolic brain networks associated with cognitive function in Parkinson's disease Neuroimage 34 714 723 17113310 10.1016/j.neuroimage.2006.09.003 (Pubitemid 44827754)
19. C Huang P Mattis K Perrine N Brown V Dhawan D Eidelberg 2008 Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease Neurology 70 1470 1477 18367705 10.1212/01.wnl.0000304050.05332.9c 1:CAS:528:DC%2BD1cXksFantrs%3D (Pubitemid 351521942)
20. AJ Hughes SE Daniel S Blankson AJ Lees 1993 A clinicopathologic study of 100 cases of Parkinson's disease Arch Neurol 50 140 148 8431132 1:STN:280:DyaK3s7lvFentA%3D%3D (Pubitemid 23054795)
21. DM Jacobs K Marder LJ Cote M Sano Y Stern R Mayeux 1995 Neuropsychological characteristics of preclinical dementi in Parkinson's disease Neurology 45 1691 1696 7675228 1:STN:280:DyaK2MvgsFKhug%3D%3D
22. CC Janvin D Aarsland JP Larsen 2005 Cognitive predictors of dementia in Parkinson's disease: a community based, 4-year longitudinal study J Geriatr Psychiatry Neurol 18 149 154 16100104 10.1177/0891988705277540 (Pubitemid 41284965)
23. CC Janvin JP Larsen D Aarsland K Hugdahl 2006 Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia Mov Disord 21 1343 1349 16721732 10.1002/mds.20974 (Pubitemid 44613283)
24. AD Korczyn H Reichmann 2006 Dementia with Lewy bodies J Neurol Sci 248 3 8 17034818 10.1016/j.jns.2006.05.055 (Pubitemid 44647297)
25. J Kulisevsky J Pagonabarraga 2009 Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment Mov Disord 24 1103 1110 19353727 10.1002/mds.22506
26. AJ Lees E Smith 1983 Cognitive deficits in the early stages of Parkinson's disease Brain 106 257 270 6850270 10.1093/brain/106.2.257 (Pubitemid 13098511)
27. I Liepelt M Reimold W Maetzler, et al. 2009 Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F] FDG-PET Mov Disord 24 1504 1511 19489069 10.1002/mds.22662
28. CF Lippa JE Duda M Grossman, et al. 2007 DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 68 812 819 17353469 10.1212/01.wnl.0000256715.13907.d3 1:CAS:528:DC%2BD2sXisFyhu70%3D (Pubitemid 46568532)
29. F Mahieux G Fénelon A Flahault MJ Manifacier D Michelet F Boller 1998 Neuropsychological prediction of dementia in Parkinson's disease J Neurol Neurosurg Psychiatry 64 178 183 9489527 10.1136/jnnp.64.2.178 1:STN:280:DyaK1c7kvFWksw%3D%3D (Pubitemid 28159798)
30. E Mamikonyan PJ Moberg A Siderowf, et al. 2009 Mild cognitive impairment is common in Parkinson's disease patients with normal mini-mental state examination (MMSE) scores Parkinsonism Relat Disord 15 226 231 18595765 10.1016/j.parkreldis.2008.05.006
31. D Muslimovic B Post JD Speelman B Schmand 2005 Cognitive profile of patients with newly diagnosed Parkinson disease Neurology 65 1239 1245 16247051 10.1212/01.wnl.0000180516.69442.95 (Pubitemid 41508217)
32. RC Petersen 2004 Mild cognitive impairment as a diagnostic entity J Intern Med 256 183 194 15324362 10.1111/j.1365-2796.2004.01388.x 1:STN:280:DC%2BD2cvhvFCkug%3D%3D (Pubitemid 39222988)
33. RC Petersen GE Smith SC Waring RJ Vnik EG Tantalos E Kokmen 1999 Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 303 308 10190820 10.1001/archneur.56.3.303 1:STN:280:DyaK1M3gsFSqtw%3D%3D (Pubitemid 29120227)
34. M Piccirilli P D'Alessandro G Finali GL Piccinin L Agostini 1989 Frontal lobe dysfunction in Parkinson's disease: prognostic value for dementia? Eur Neurol 29 71 76 2707295 10.1159/000116381 1:STN:280:DyaL1M3htFShsQ%3D%3D (Pubitemid 19077098)
35. H Shimada S Hirano H Shinotoh, et al. 2009 Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET Neurology 73 273 278 19474411 10.1212/WNL.0b013e3181ab2b58 1:CAS:528:DC%2BD1MXovVShtrw%3D
36. A Siderowf SX Xie H Hurtig, et al. 2010 CSF amyloid beta 1-42 predicts cognitive decline in Parkinson disease Neurology 75 1055 1061 20720189 10.1212/WNL.0b013e3181f39a78 1:CAS:528:DC%2BC3cXhtFOrsbjI
37. R Tomer J Aharon-Peretz Z Tsitrinbaum 2007 Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease Neuropsychologia 45 357 367 16876208 10.1016/j.neuropsychologia.2006.06.014 (Pubitemid 44828768)
38. AI Tröster 2008 Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers Neuropsychol Rev 18 103 119 18322801 10.1007/s11065-008-9055-0
39. CH Williams-Gray T Foltynie CE Brayne TW Robbins RA Barker 2007 Evolution of cognitive dysfunction in an incident Parkinson's disease cohort Brain 130 1787 1798 17535834 10.1093/brain/awm111 1:STN:280:DC%2BD2szmvVagsg%3D%3D (Pubitemid 47343805)
40. E Wolters H Braak 2006 Parkinson's disease: promotor clinico-pathological correlations J Neural Transm 70 Suppl 309 319 10.1007/978-3-211-45295-0-47 (Pubitemid 44622216)